Article

newatlas.com on 2021-06-15 03:33

Novavax COVID-19 vaccine hits 90% efficacy in large US trial

Novavax has announced data from its Phase 3 COVID-19 vaccine trial, revealing over 90 percent protection from symptomatic infection and 100 percent ...

Related news

Coronavirus | Novavax claims 90% efficacy for its vaccine The Hindu
India , Gavi , South Africa , United Kingdom , Europe
Novavax Reports Over 90% Efficacy For Its Covid Vaccine—Including Against Variants Forbes
United Kingdom , United States , Ducey
PNovavax Covid-19 vaccine shows 85.6% efficacy pendect.com
South Africa , United Kingdom
New vaccine on the horizon as Novavax reports 90 per cent efficacy timesofmalta.com
Malta , Mexico
Large study finds Novavax COVID-19 shot about 90% effective staradvertiser.com
India , Gavi , South Africa , Gaithersburg , United Kingdom
Novavax: Large study finds covid-19 shot about 90% effective nwaonline.com
India , Gavi , South Africa , Gaithersburg , United Kingdom
Novavax: Large study finds COVID-19 shot about 90% effective kentucky.com
India , Gavi , South Africa , Gaithersburg , United Kingdom
HNovavax: Large Study Finds COVID-19 Shot About 90% Effective hamodia.com
India , Gavi , South Africa , United Kingdom , Europe